What is Femasys' operating income?

Femasys' total operating income in 2025 was -$17.59 million, based on the following breakdown: Total Gross Profit: $1.42 million Total Operating Expenses: $19.01 million

Femasys (FEMY) Financials

$3.01 -0.04 (-1.31%)

Closing price 07/17/2026 04:00 PM Eastern

Extended Trading

$3.02 +0.01 (+0.17%)

As of 07/17/2026 04:10 PM Eastern

Compare

Annual Income Statements for Femasys

This table shows Femasys' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-6.91	-7.54	-11	-14	-19	-19
Consolidated Net Income / (Loss)	-6.91	-7.54	-11	-14	-19	-19
Net Income / (Loss) Continuing Operations	-6.91	-7.54	-11	-14	-19	-19
Total Pre-Tax Income	-6.91	-7.53	-11	-14	-19	-19
Total Operating Income	-6.93	-8.34	-12	-15	-18	-18
Total Gross Profit	0.73	0.81	0.76	0.69	1.08	1.42
Total Revenue	1.04	1.18	1.21	1.07	1.63	2.29
Operating Revenue	-	1.18	1.21	1.07	1.63	2.29
Total Cost of Revenue	0.31	0.37	0.44	0.38	0.54	0.87
Operating Cost of Revenue	-	0.37	0.44	0.38	0.54	0.87
Total Operating Expenses	7.66	9.15	12	15	19	19
Selling, General & Admin Expense	2.54	4.26	5.43	6.86	6.33	6.65
Marketing Expense	0.31	0.21	0.56	0.65	4.03	4.44
Research & Development Expense	4.13	4.08	5.81	7.21	8.22	7.58
Depreciation Expense	0.68	0.59	0.56	0.48	0.30	0.34
Total Other Income / (Expense), net	0.02	0.80	0.21	0.27	-1.02	-1.04
Interest Expense	0.01	0.02	0.01	0.17	1.60	1.89
Interest & Investment Income	0.02	0.00	0.23	0.43	0.58	0.10
Other Income / (Expense), net	0.01	0.82	-0.00	-	0.00	0.75
Income Tax Expense	0.00	0.00	0.01	0.00	0.01	0.00
Basic Earnings per Share	($7.20)	($1.12)	($0.96)	($0.93)	($0.85)	($0.47)
Weighted Average Basic Shares Outstanding	959.86K	6.71M	11.82M	15.38M	22.27M	39.55M
Diluted Earnings per Share	($7.20)	($1.12)	($0.96)	($0.93)	($0.85)	($0.47)
Weighted Average Diluted Shares Outstanding	959.86K	6.71M	11.82M	15.38M	22.27M	39.55M

This table shows Femasys' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-4.00	-4.41	-3.60	-4.68	-5.41	-5.12	-5.90	-4.59	-4.19	-3.95	0.33
Consolidated Net Income / (Loss)	-4.00	-4.41	-3.60	-4.68	-5.41	-5.12	-5.90	-4.59	-4.19	-3.95	0.85
Net Income / (Loss) Continuing Operations	-4.00	-4.41	-3.60	-4.68	-5.41	-5.12	-5.90	-4.59	-4.19	-3.95	0.85
Total Pre-Tax Income	-4.00	-4.41	-3.60	-4.69	-5.41	-5.11	-5.90	-4.59	-4.19	-3.94	0.85
Total Operating Income	-4.08	-4.45	-3.46	-4.48	-5.12	-4.72	-5.46	-3.85	-3.65	-4.62	-4.22
Total Gross Profit	0.16	0.13	0.18	0.15	0.36	0.39	0.22	0.25	0.44	0.51	0.27
Total Revenue	0.24	0.21	0.27	0.22	0.55	0.58	0.34	0.41	0.73	0.81	0.42
Operating Revenue	0.24	0.21	0.27	0.22	0.55	0.58	0.34	0.41	0.73	0.81	0.42
Total Cost of Revenue	0.09	0.08	0.09	0.07	0.19	0.19	0.12	0.16	0.29	0.30	0.16
Operating Cost of Revenue	0.09	0.08	0.09	0.07	0.19	0.19	0.12	0.16	0.29	0.30	0.16
Total Operating Expenses	4.24	4.58	3.65	4.63	5.48	5.11	5.68	4.10	4.09	5.13	4.49
Selling, General & Admin Expense	1.97	2.22	1.50	1.61	1.53	1.68	1.72	1.62	1.48	1.83	1.78
Marketing Expense	0.07	0.21	0.30	0.98	1.57	1.18	0.91	0.98	1.14	1.41	1.32
Research & Development Expense	2.07	2.07	1.77	1.98	2.30	2.17	2.97	1.41	1.38	1.81	1.31
Depreciation Expense	0.13	0.09	0.07	0.07	0.08	0.08	0.08	0.09	0.09	0.09	0.08
Total Other Income / (Expense), net	0.08	0.04	-0.14	-0.20	-0.29	-0.39	-0.44	-0.73	-0.54	0.68	5.07
Interest Expense	0.01	-	0.36	0.39	0.41	0.44	0.46	0.49	0.53	0.41	0.18
Interest & Investment Income	0.09	0.20	0.22	0.18	0.12	0.05	0.02	0.02	0.02	0.05	0.05
Other Income / (Expense), net	-	-	-	0.00	0.00	-	0.00	-0.26	-0.03	-	5.20
Income Tax Expense	0.00	-	0.00	-0.00	0.00	0.01	-0.00	0.00	0.00	0.01	0.00
Basic Earnings per Share	($0.26)	($0.20)	($0.17)	($0.21)	($0.24)	($0.23)	($0.23)	($0.16)	($0.10)	$0.02	$0.00
Weighted Average Basic Shares Outstanding	15.09M	15.38M	21.78M	22.22M	22.23M	22.27M	25.15M	28.88M	41.02M	39.55M	66.65M
Diluted Earnings per Share	($0.26)	($0.20)	($0.17)	($0.21)	($0.24)	($0.23)	($0.23)	($0.16)	($0.10)	$0.02	$0.00
Weighted Average Diluted Shares Outstanding	15.09M	15.38M	21.78M	22.22M	22.23M	22.27M	25.15M	28.88M	41.02M	39.55M	78.10M
Weighted Average Basic & Diluted Shares Outstanding	21.65M	22.10M	22.22M	22.23M	22.90M	27.15M	-	-	-	0.00	60.39M

This table details how cash moves in and out of Femasys' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-3.09	21	-12	8.75	-18	5.81
Net Cash From Operating Activities	-4.93	-7.93	-11	-11	-19	-19
Net Cash From Continuing Operating Activities	-4.93	-7.93	-11	-11	-19	-19
Net Income / (Loss) Continuing Operations	-6.91	-7.54	-11	-14	-19	-19
Consolidated Net Income / (Loss)	-6.91	-7.54	-11	-14	-19	-19
Depreciation Expense	0.56	0.55	0.54	0.48	0.28	0.30
Amortization Expense	0.54	0.41	0.35	0.54	1.79	1.94
Non-Cash Adjustments To Reconcile Net Income	0.32	-1.04	0.23	0.72	0.44	0.26
Changes in Operating Assets and Liabilities, net	0.56	-0.32	-0.46	1.23	-3.14	-2.56
Net Cash From Investing Activities	0.97	-0.31	-0.41	-0.14	-0.85	-0.63
Net Cash From Continuing Investing Activities	0.97	-0.31	-0.41	-0.14	-0.85	-0.63
Purchase of Property, Plant & Equipment	-0.01	-0.31	-0.41	-0.14	-0.76	-0.53
Acquisitions	-0.02	-	-	0.00	-0.09	-0.11
Net Cash From Financing Activities	0.87	30	-0.68	20	2.03	25
Net Cash From Continuing Financing Activities	0.87	30	-0.68	20	2.03	25
Repayment of Debt	0.00	-0.44	-0.51	-1.14	0.00	-7.85
Repurchase of Common Equity	-0.08	-1.58	-0.23	-0.23	0.00	-1.74
Issuance of Debt	0.81	-	0.00	6.85	0.00	12
Issuance of Common Equity	0.15	32	0.08	12	2.03	19
Other Financing Activities, net	-0.02	-0.02	-0.02	3.12	0.00	3.32
Cash Interest Paid	0.01	0.02	0.01	0.01	0.11	0.01
Cash Income Taxes Paid	0.00	0.00	0.01	0.00	0.01	0.01

This table details how cash moves in and out of Femasys' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-2.01	13	-3.88	-4.31	-5.91	-4.16	0.37	-0.60	1.35	4.70	-3.88
Net Cash From Operating Activities	-2.86	-3.04	-4.57	-4.33	-5.47	-5.07	-4.77	-4.35	-5.39	-4.19	-4.14
Net Cash From Continuing Operating Activities	-2.86	-3.04	-4.57	-4.33	-5.47	-5.07	-4.77	-4.35	-5.39	-4.19	-4.14
Net Income / (Loss) Continuing Operations	-4.00	-4.41	-3.60	-4.68	-5.41	-5.12	-5.90	-4.59	-4.19	-3.95	0.85
Consolidated Net Income / (Loss)	-4.00	-4.41	-3.60	-4.68	-5.41	-5.12	-5.90	-4.59	-4.19	-3.95	0.85
Depreciation Expense	0.12	0.09	0.07	0.06	0.07	0.07	0.08	0.08	0.07	0.07	0.07
Amortization Expense	0.13	0.26	0.41	0.44	0.46	0.48	0.50	0.53	0.57	0.35	0.31
Non-Cash Adjustments To Reconcile Net Income	0.69	0.05	0.08	0.10	0.13	0.13	0.41	0.20	0.17	-0.52	-3.53
Changes in Operating Assets and Liabilities, net	0.20	0.98	-1.53	-0.24	-0.72	-0.64	0.15	-0.57	-2.00	-0.14	-1.84
Net Cash From Investing Activities	-0.03	-0.04	-0.09	-0.21	-0.44	-0.11	-0.10	-0.10	-0.24	-0.20	-0.08
Net Cash From Continuing Investing Activities	-0.03	-0.04	-0.09	-0.21	-0.44	-0.11	-0.10	-0.10	-0.24	-0.20	-0.08
Purchase of Property, Plant & Equipment	-0.03	-0.04	-0.06	-0.18	-0.41	-0.11	-0.10	-0.09	-0.19	-0.14	-0.08
Net Cash From Financing Activities	0.87	16	0.78	0.22	-	1.03	5.23	3.85	6.98	9.08	0.34
Net Cash From Continuing Financing Activities	0.87	16	0.78	0.22	-	1.03	5.23	3.85	6.98	9.08	0.34
Issuance of Common Equity	-	7.66	0.80	0.20	-	1.03	5.23	4.49	8.00	1.52	0.34
Cash Interest Paid	0.01	-	-	-	-	0.11	0.00	-	-	0.00	0.00
Cash Income Taxes Paid	0.00	-	-	-	0.00	-	0.00	-	-	0.00	0.00

This table presents Femasys' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	7.61	29	17	28	12	21
Total Current Assets	3.86	26	14	23	8.02	16
Cash & Equivalents	3.32	25	13	22	3.45	9.27
Accounts Receivable	0.13	0.08	0.08	0.10	0.49	0.62
Inventories, net	0.13	0.21	0.44	0.67	3.05	5.74
Other Current Assets	0.28	0.56	0.66	0.70	1.04	0.83
Plant, Property, & Equipment, net	1.83	1.60	1.48	1.11	1.60	1.90
Plant, Property & Equipment, gross	4.03	4.32	4.70	4.66	5.34	11
Accumulated Depreciation	2.20	2.72	3.22	3.55	3.74	3.80
Total Noncurrent Assets	1.92	1.35	1.28	3.47	2.83	2.37
Intangible Assets	0.07	0.03	0.00	0.00	0.07	0.13
Other Noncurrent Operating Assets	1.85	1.32	1.28	3.47	2.76	2.24
Total Liabilities & Shareholders' Equity	7.61	29	17	28	12	21
Total Liabilities	4.08	2.24	1.65	9.40	10	15
Total Current Liabilities	2.89	1.69	1.53	3.05	8.58	3.64
Accounts Payable	0.67	0.45	0.51	1.14	1.42	1.83
Accrued Expenses	1.12	0.60	0.46	1.44	1.15	1.32
Other Current Liabilities	0.47	0.46	0.42	0.47	0.61	0.49
Total Noncurrent Liabilities	1.19	0.55	0.13	6.35	1.56	11
Long-Term Debt	0.18	-	0.00	4.26	0.00	3.18
Capital Lease Obligations	-	-	-	-	-	1.03
Other Noncurrent Operating Liabilities	1.01	0.55	0.13	2.09	1.56	7.01
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-52	26	15	18	2.30	5.87
Total Preferred & Common Equity	-52	26	15	18	2.30	5.87
Total Common Equity	-52	26	15	18	2.30	5.87
Common Stock	23	108	109	124	128	147
Retained Earnings	-75	-83	-94	-108	-127	-146
Treasury Stock	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06
Other Equity Adjustments	0.70	0.70	0.57	2.79	1.86	5.25

This table presents Femasys' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	15	24	20	16	13	14	16	16
Total Current Assets	10	20	16	11	9.13	9.75	12	12
Cash & Equivalents	8.69	18	14	7.61	3.82	3.22	4.57	5.39
Accounts Receivable	0.10	0.12	0.09	0.38	0.23	0.25	0.57	0.17
Inventories, net	0.60	0.97	1.32	1.94	3.86	5.23	5.78	6.11
Other Current Assets	0.83	0.96	1.00	1.37	1.22	1.05	1.32	0.68
Plant, Property, & Equipment, net	1.16	1.21	1.26	1.39	1.58	1.60	1.75	3.10
Plant, Property & Equipment, gross	4.75	4.83	4.94	5.14	5.39	5.48	11	12
Accumulated Depreciation	3.59	3.62	3.68	3.75	3.82	3.88	3.96	3.87
Total Noncurrent Assets	3.47	3.27	3.08	2.90	2.57	2.43	2.29	1.05
Intangible Assets	0.00	0.03	0.04	0.07	0.06	0.06	0.13	0.12
Other Noncurrent Operating Assets	3.47	3.24	3.04	2.83	2.51	2.37	2.16	0.92
Total Liabilities & Shareholders' Equity	15	24	20	16	13	14	16	16
Total Liabilities	4.41	8.76	9.03	9.62	11	12	12	9.21
Total Current Liabilities	2.19	2.36	2.46	2.87	9.84	11	11	3.16
Accounts Payable	0.85	1.10	0.95	1.12	2.33	3.26	2.17	1.60
Accrued Expenses	0.57	0.67	0.89	1.13	1.17	1.05	1.09	1.08
Other Current Liabilities	0.48	0.59	0.63	0.62	0.58	0.57	0.49	0.48
Total Noncurrent Liabilities	2.22	6.41	6.56	6.75	1.44	1.31	1.19	6.05
Long-Term Debt	-	4.47	4.76	5.07	-	-	-	3.34
Capital Lease Obligations	-	-	-	-	-	-	1.15	0.91
Other Noncurrent Operating Liabilities	2.22	1.93	1.80	1.68	1.44	1.31	0.04	1.80
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	10	16	11	5.97	2.00	1.51	4.56	7.29
Total Preferred & Common Equity	10	16	11	5.97	2.00	1.51	4.56	7.29
Total Common Equity	10	16	11	5.97	2.00	1.51	4.56	7.35
Common Stock	113	125	125	125	133	137	140	147
Retained Earnings	-104	-112	-117	-122	-133	-138	-142	-145
Other Equity Adjustments	1.58	2.63	2.61	2.61	1.86	1.82	6.73	5.25

This table displays calculated financial ratios and metrics derived from Femasys' official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	0.00	11,799,720.00	11,813,610.00	21,649,623.00	22,898,468.00	27,149,971.00
DEI Adjusted Shares Outstanding	0.00	11,799,720.00	11,813,610.00	21,649,623.00	22,898,468.00	27,149,971.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	-0.64	-0.96	-0.66	-0.82	-0.69
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	13.66%	2.25%	-11.13%	51.97%	40.77%
EBITDA Growth	0.00%	-12.54%	-63.46%	-25.94%	-16.52%	7.13%
EBIT Growth	0.00%	-8.60%	-54.32%	-25.04%	-22.59%	5.33%
NOPAT Growth	0.00%	-20.25%	-39.15%	-25.07%	-22.59%	1.11%
Net Income Growth	0.00%	-9.01%	-51.16%	-25.04%	-32.07%	1.00%
EPS Growth	0.00%	84.44%	14.29%	3.13%	8.60%	44.71%
Operating Cash Flow Growth	0.00%	-60.77%	-35.32%	-5.11%	-72.37%	3.87%
Free Cash Flow Firm Growth	0.00%	0.00%	-34.57%	2.08%	-83.28%	43.94%
Invested Capital Growth	0.00%	69.95%	39.95%	-63.06%	376.02%	-80.93%
Revenue Q/Q Growth	0.00%	0.00%	-1.64%	-1.93%	29.23%	11.24%
EBITDA Q/Q Growth	0.00%	0.00%	-6.59%	-10.77%	-0.43%	4.68%
EBIT Q/Q Growth	0.00%	0.00%	-5.89%	-11.10%	-1.56%	4.81%
NOPAT Q/Q Growth	0.00%	0.00%	-5.86%	-11.10%	-1.56%	0.56%
Net Income Q/Q Growth	0.00%	0.00%	-4.87%	-11.91%	-3.94%	5.93%
EPS Q/Q Growth	0.00%	0.00%	-233.33%	5.10%	-3.66%	34.72%
Operating Cash Flow Q/Q Growth	0.00%	-14.05%	-6.13%	-1.51%	-11.71%	4.54%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	2.99%	-15.84%	47.46%
Invested Capital Q/Q Growth	0.00%	0.00%	6.14%	-56.02%	24.27%	-89.74%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	70.47%	68.60%	63.36%	64.54%	66.55%	61.96%
EBITDA Margin	-561.08%	-555.58%	-888.18%	-1,258.66%	-965.02%	-636.62%
Operating Margin	-667.99%	-706.70%	-961.71%	-1,353.43%	-1,091.75%	-766.95%
EBIT Margin	-667.02%	-637.32%	-961.90%	-1,353.43%	-1,091.75%	-734.19%
Profit (Net Income) Margin	-666.24%	-638.97%	-944.62%	-1,329.06%	-1,155.03%	-812.27%
Tax Burden Percent	100.03%	100.05%	100.06%	100.03%	100.05%	100.01%
Interest Burden Percent	99.86%	100.21%	98.15%	98.17%	105.74%	110.63%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-476.63%	-424.62%	-391.11%	-612.43%	-483.16%	-485.57%
ROIC Less NNEP Spread (ROIC-NNEP)	-394.48%	-412.06%	-373.61%	-585.41%	-401.03%	-78.43%
Return on Net Nonoperating Assets (RNNOA)	280.62%	374.13%	336.30%	527.62%	300.98%	29.77%
Return on Equity (ROE)	-196.01%	-50.49%	-54.81%	-84.82%	-182.18%	-455.80%
Cash Return on Invested Capital (CROIC)	0.00%	-476.44%	-424.41%	-520.34%	-613.72%	-349.64%
Operating Return on Assets (OROA)	-91.02%	-41.56%	-51.03%	-64.99%	-88.48%	-101.52%
Return on Assets (ROA)	-90.91%	-41.67%	-50.11%	-63.81%	-93.61%	-112.32%
Return on Common Equity (ROCE)	2,879.72%	43.12%	-54.81%	-84.82%	-182.18%	-455.80%
Return on Equity Simple (ROE_SIMPLE)	13.35%	-28.63%	-74.75%	-77.63%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-4.85	-5.84	-8.12	-10	-12	-12
NOPAT Margin	-467.59%	-494.69%	-673.19%	-947.40%	-764.23%	-536.87%
Net Nonoperating Expense Percent (NNEP)	-82.15%	-12.56%	-17.50%	-27.02%	-82.13%	-407.14%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-44.92%	-161.47%	-122.16%
Cost of Revenue to Revenue	29.53%	31.40%	36.64%	35.46%	33.45%	38.04%
SG&A Expenses to Revenue	245.11%	361.28%	450.23%	639.76%	388.31%	289.80%
R&D to Revenue	397.97%	346.22%	481.98%	672.47%	504.36%	330.43%
Operating Expenses to Revenue	738.45%	775.30%	1,025.07%	1,417.98%	1,158.30%	828.91%
Earnings before Interest and Taxes (EBIT)	-6.92	-7.52	-12	-15	-18	-17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-5.82	-6.55	-11	-13	-16	-15
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	1.75	0.70	1.15	10.93	0.00
Price to Tangible Book Value (P/TBV)	0.00	1.75	0.70	1.15	11.25	0.00
Price to Revenue (P/Rev)	33.19	39.01	8.81	19.69	15.46	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	85.74	12.38	0.00	4.08	6.37	0.00
Enterprise Value to Revenue (EV/Rev)	84.11	18.15	0.00	3.41	16.66	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.23	0.01	0.01	0.23	2.35	0.72
Long-Term Debt to Equity	0.05	0.00	0.00	0.23	0.00	0.72
Financial Leverage	-0.71	-0.91	-0.90	-0.90	-0.75	-0.38
Leverage Ratio	2.16	1.21	1.09	1.33	1.95	4.06
Compound Leverage Factor	2.15	1.21	1.07	1.30	2.06	4.49
Debt to Total Capital	18.72%	0.68%	0.92%	18.83%	70.11%	41.77%
Short-Term Debt to Total Capital	14.51%	0.68%	0.92%	0.00%	70.11%	0.00%
Long-Term Debt to Total Capital	4.20%	0.00%	0.00%	18.83%	0.00%	41.77%
Preferred Equity to Total Capital	0.40%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1,275.07%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-1,194.18%	99.32%	99.08%	81.17%	29.89%	58.24%
Debt to EBITDA	-0.14	-0.03	-0.01	-0.32	-0.34	-0.29
Net Debt to EBITDA	0.43	3.75	1.20	1.29	-0.12	0.35
Long-Term Debt to EBITDA	-0.03	0.00	0.00	-0.32	0.00	-0.29
Debt to NOPAT	-0.17	-0.03	-0.02	-0.42	-0.43	-0.34
Net Debt to NOPAT	0.52	4.22	1.58	1.72	-0.16	0.41
Long-Term Debt to NOPAT	-0.04	0.00	0.00	-0.42	0.00	-0.34
Altman Z-Score	-11.49	8.43	-5.24	-4.94	-17.46	0.00
Noncontrolling Interest Sharing Ratio	1,569.21%	185.40%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	1.34	15.15	9.25	7.59	0.93	4.53
Quick Ratio	1.19	14.70	8.53	7.14	0.46	2.72
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-6.55	-8.81	-8.63	-16	-8.87
Operating Cash Flow to CapEx	-59,063.88%	-2,584.43%	-2,633.77%	-7,838.23%	-2,552.69%	-3,560.06%
Free Cash Flow to Firm to Interest Expense	0.00	-340.58	-654.46	-52.17	-9.86	-4.69
Operating Cash Flow to Interest Expense	-392.98	-412.50	-797.09	-68.21	-12.13	-9.88
Operating Cash Flow Less CapEx to Interest Expense	-393.64	-428.46	-827.35	-69.08	-12.60	-10.16
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.14	0.07	0.05	0.05	0.08	0.14
Accounts Receivable Turnover	8.25	11.23	14.92	12.16	5.55	4.15
Inventory Turnover	2.33	2.18	1.37	0.69	0.29	0.20
Fixed Asset Turnover	0.57	0.69	0.78	0.83	1.20	1.31
Accounts Payable Turnover	0.45	0.66	0.92	0.46	0.43	0.54
Days Sales Outstanding (DSO)	44.24	32.49	24.47	30.03	65.79	87.93
Days Inventory Outstanding (DIO)	156.44	167.36	266.35	530.04	1,243.71	1,838.09
Days Payable Outstanding (DPO)	802.95	551.79	394.90	791.61	856.35	679.70
Cash Conversion Cycle (CCC)	-602.28	-351.94	-104.08	-231.54	453.15	1,246.32
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	1.02	1.73	2.42	0.89	4.26	0.81
Invested Capital Turnover	1.02	0.86	0.58	0.65	0.63	0.90
Increase / (Decrease) in Invested Capital	0.00	0.71	0.69	-1.53	3.36	-3.45
Enterprise Value (EV)	87	21	-2.19	3.65	27	0.00
Market Capitalization	34	46	11	21	25	0.00
Book Value per Share	($54.00)	$2.23	$1.29	$0.85	$0.10	$0.15
Tangible Book Value per Share	($54.07)	$2.23	$1.29	$0.85	$0.10	$0.15
Total Capital	4.34	27	15	23	7.71	10
Total Debt	0.81	0.18	0.14	4.26	5.41	4.21
Total Long-Term Debt	0.18	0.00	0.00	4.26	0.00	4.21
Net Debt	-2.51	-25	-13	-17	1.95	-5.06
Capital Expenditures (CapEx)	0.01	0.31	0.41	0.14	0.76	0.53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.72	-0.66	-0.22	-1.59	1.39	3.55
Debt-free Net Working Capital (DFNWC)	1.60	24	13	20	4.85	13
Net Working Capital (NWC)	0.97	24	13	20	-0.56	13
Net Nonoperating Expense (NNE)	2.06	1.70	3.27	4.09	6.37	6.32
Net Nonoperating Obligations (NNO)	-2.51	-25	-13	-17	1.95	-5.06
Total Depreciation and Amortization (D&A)	1.10	0.96	0.89	1.02	2.06	2.24
Debt-free, Cash-free Net Working Capital to Revenue	-165.49%	-56.17%	-17.99%	-148.53%	85.57%	154.96%
Debt-free Net Working Capital to Revenue	154.60%	2,044.64%	1,056.61%	1,877.28%	297.45%	559.02%
Net Working Capital to Revenue	93.90%	2,029.29%	1,044.89%	1,877.28%	-34.40%	559.02%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($1.12)	$0.00	($0.93)	($0.85)	($0.47)
Adjusted Weighted Average Basic Shares Outstanding	0.00	6.71M	0.00	15.38M	22.27M	39.55M
Adjusted Diluted Earnings per Share	$0.00	($1.12)	$0.00	($0.93)	($0.85)	($0.47)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	6.71M	0.00	15.38M	22.27M	39.55M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	11.80M	0.00	22.10M	27.15M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-4.85	-5.84	-8.12	-10	-12	-12
Normalized NOPAT Margin	-467.59%	-494.69%	-673.19%	-947.40%	-764.23%	-536.87%
Pre Tax Income Margin	-666.06%	-638.63%	-944.10%	-1,328.66%	-1,154.44%	-812.21%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	-551.51	-391.05	-861.75	-87.72	-11.09	-8.90
NOPAT to Interest Expense	-386.62	-303.53	-603.10	-61.41	-7.76	-6.51
EBIT Less CapEx to Interest Expense	-552.18	-407.01	-892.01	-88.59	-11.57	-9.18
NOPAT Less CapEx to Interest Expense	-387.28	-319.50	-633.37	-62.28	-8.24	-6.79
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-1.08%	-20.94%	-2.04%	-1.61%	0.00%	-9.31%

This table displays calculated financial ratios and metrics derived from Femasys' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	15,073,153.00	21,649,623.00	22,099,347.00	22,220,718.00	22,232,799.00	22,898,468.00	27,149,971.00	27,149,971.00	27,149,971.00	27,149,971.00	27,149,971.00
DEI Adjusted Shares Outstanding	15,073,153.00	21,649,623.00	22,099,347.00	22,220,718.00	22,232,799.00	22,898,468.00	27,149,971.00	27,149,971.00	27,149,971.00	27,149,971.00	27,149,971.00
DEI Earnings Per Adjusted Shares Outstanding	-0.27	-0.20	-0.16	-0.21	-0.24	-0.22	-0.22	-0.17	-0.15	-0.15	0.01
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-29.67%	-9.02%	-7.77%	-30.90%	127.09%	172.90%	25.86%	84.78%	31.44%	39.86%	24.50%
EBITDA Growth	-35.00%	-47.05%	-5.19%	-45.89%	-19.89%	-1.64%	-63.99%	11.94%	33.75%	-0.83%	127.62%
EBIT Growth	-33.50%	-48.30%	-13.84%	-52.66%	-25.41%	-6.14%	-57.70%	8.27%	28.10%	2.11%	117.82%
NOPAT Growth	-33.50%	-48.30%	-13.84%	-52.66%	-25.41%	-6.14%	-57.70%	14.07%	28.62%	2.11%	-10.49%
Net Income Growth	-34.00%	-52.39%	-22.17%	-61.90%	-35.33%	-16.17%	-63.82%	2.11%	22.45%	22.90%	114.35%
EPS Growth	-4.00%	20.00%	32.00%	4.55%	7.69%	-15.00%	-35.29%	23.81%	58.33%	108.70%	100.00%
Operating Cash Flow Growth	-4.60%	-5.86%	-72.54%	-57.84%	-91.71%	-67.15%	-4.31%	-0.60%	1.59%	17.53%	13.05%
Free Cash Flow Firm Growth	4.33%	43.14%	3.13%	-73.57%	-90.66%	-320.17%	-123.15%	-32.92%	-41.69%	103.16%	-16.64%
Invested Capital Growth	-10.84%	-63.06%	2.22%	14.33%	68.45%	376.02%	75.55%	76.05%	131.08%	-80.93%	56.15%
Revenue Q/Q Growth	-23.76%	-12.79%	27.23%	-18.31%	150.54%	4.81%	-41.32%	19.93%	78.22%	11.52%	-47.76%
EBITDA Q/Q Growth	-40.32%	-7.03%	27.31%	-33.64%	-15.31%	9.27%	-17.29%	28.24%	13.24%	-38.09%	132.13%
EBIT Q/Q Growth	-39.01%	-9.02%	22.18%	-29.44%	-14.20%	7.73%	-15.63%	24.71%	10.49%	-25.62%	121.05%
NOPAT Q/Q Growth	-39.01%	-9.02%	22.18%	-29.44%	-14.20%	7.73%	-15.63%	29.47%	5.14%	-26.52%	-30.52%
Net Income Q/Q Growth	-38.13%	-10.35%	18.39%	-30.14%	-15.46%	5.27%	-15.09%	22.23%	8.53%	5.83%	121.42%
EPS Q/Q Growth	-18.18%	23.08%	15.00%	-23.53%	-14.29%	4.17%	0.00%	30.43%	37.50%	120.00%	-100.00%
Operating Cash Flow Q/Q Growth	-4.18%	-6.31%	-50.47%	5.29%	-26.53%	7.31%	6.10%	8.66%	-23.77%	22.31%	1.00%
Free Cash Flow Firm Q/Q Growth	-31.34%	39.17%	-55.76%	-39.47%	-44.27%	-34.06%	17.27%	16.92%	-53.79%	102.99%	-3,154.56%
Invested Capital Q/Q Growth	-6.29%	-56.02%	150.82%	10.62%	38.06%	24.27%	-7.50%	10.93%	81.21%	-89.74%	657.31%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.73%	63.26%	67.35%	66.98%	65.61%	66.92%	65.64%	61.35%	59.71%	62.73%	62.67%
EBITDA Margin	-1,567.49%	-1,923.60%	-1,099.04%	-1,798.08%	-827.56%	-716.44%	-1,431.98%	-856.84%	-417.12%	-516.53%	317.72%
Operating Margin	-1,670.18%	-2,087.89%	-1,277.07%	-2,023.69%	-922.39%	-812.03%	-1,600.11%	-941.09%	-500.93%	-568.33%	-994.03%
EBIT Margin	-1,670.18%	-2,087.89%	-1,277.07%	-2,023.69%	-922.39%	-812.03%	-1,600.11%	-1,004.61%	-504.54%	-568.33%	228.97%
Profit (Net Income) Margin	-1,635.66%	-2,069.56%	-1,327.55%	-2,115.08%	-974.73%	-881.00%	-1,727.94%	-1,120.52%	-575.11%	-485.66%	199.13%
Tax Burden Percent	100.00%	100.10%	100.00%	99.96%	100.02%	100.20%	99.93%	100.00%	100.00%	100.14%	100.00%
Interest Burden Percent	97.93%	99.02%	103.95%	104.56%	105.65%	108.28%	108.07%	111.54%	113.99%	85.34%	86.97%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-592.17%	-944.77%	-422.53%	-578.44%	-298.07%	-359.37%	-615.60%	-362.81%	-127.42%	-359.82%	-468.29%
ROIC Less NNEP Spread (ROIC-NNEP)	-582.72%	-936.22%	-412.53%	-562.55%	-264.72%	-335.92%	-579.27%	-298.81%	-526.53%	-313.77%	792.21%
Return on Net Nonoperating Assets (RNNOA)	494.31%	843.79%	347.04%	454.05%	176.63%	252.11%	375.80%	138.31%	-41.04%	119.10%	68.62%
Return on Equity (ROE)	-97.85%	-100.98%	-75.48%	-124.39%	-121.43%	-107.26%	-239.80%	-224.50%	-168.46%	-240.72%	-399.67%
Cash Return on Invested Capital (CROIC)	-412.12%	-520.34%	-473.02%	-509.04%	-499.91%	-613.72%	-502.76%	-446.41%	-297.43%	-349.64%	-270.70%
Operating Return on Assets (OROA)	-104.67%	-100.25%	-70.08%	-111.17%	-76.40%	-65.81%	-144.44%	-111.33%	-65.26%	-78.59%	36.56%
Return on Assets (ROA)	-102.50%	-99.37%	-72.85%	-116.19%	-80.74%	-71.40%	-155.98%	-124.17%	-74.39%	-67.16%	31.80%
Return on Common Equity (ROCE)	-97.85%	-100.98%	-75.48%	-124.39%	-121.43%	-107.26%	-239.80%	-224.50%	-168.46%	-240.72%	-402.25%
Return on Equity Simple (ROE_SIMPLE)	-121.90%	0.00%	-95.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-2.86	-3.11	-2.42	-3.14	-3.58	-3.31	-3.82	-2.70	-2.56	-3.24	-4.22
NOPAT Margin	-1,169.12%	-1,461.52%	-893.95%	-1,416.58%	-645.68%	-568.42%	-1,120.08%	-658.76%	-350.65%	-397.83%	-994.03%
Net Nonoperating Expense Percent (NNEP)	-9.45%	-8.56%	-10.00%	-15.89%	-33.35%	-23.45%	-36.33%	-64.01%	399.11%	-46.05%	-1,260.49%
Return On Investment Capital (ROIC_SIMPLE)	-	-13.78%	-12.07%	-19.60%	-32.46%	-42.87%	-49.26%	-35.53%	-20.48%	-32.11%	-36.61%
Cost of Revenue to Revenue	35.27%	36.74%	32.65%	33.02%	34.39%	33.08%	34.36%	38.65%	40.29%	37.27%	37.33%
SG&A Expenses to Revenue	806.35%	1,039.75%	554.25%	727.74%	275.86%	288.97%	504.80%	395.09%	202.61%	224.81%	419.50%
R&D to Revenue	848.27%	971.92%	653.07%	892.11%	415.07%	372.56%	869.85%	345.60%	189.48%	222.87%	308.17%
Operating Expenses to Revenue	1,734.91%	2,151.15%	1,344.42%	2,090.67%	988.00%	878.95%	1,665.75%	1,002.44%	560.65%	631.06%	1,056.70%
Earnings before Interest and Taxes (EBIT)	-4.08	-4.45	-3.46	-4.48	-5.12	-4.72	-5.46	-4.11	-3.68	-4.62	0.97
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-3.83	-4.10	-2.98	-3.98	-4.59	-4.17	-4.89	-3.51	-3.04	-4.20	1.35
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.30	1.15	2.19	2.25	4.13	10.93	17.00	17.39	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	4.30	1.15	2.20	2.26	4.18	11.25	17.51	18.06	0.00	0.00	0.00
Price to Revenue (P/Rev)	41.09	19.69	32.65	26.66	19.58	15.46	19.97	13.90	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	17.94	4.08	9.31	6.67	6.46	6.37	9.11	6.66	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	33.40	3.41	19.91	17.43	17.56	16.66	21.12	15.41	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.03	0.23	0.29	0.42	0.85	2.35	2.89	4.03	1.74	0.72	0.58
Long-Term Debt to Equity	0.00	0.23	0.29	0.42	0.85	0.00	0.00	0.00	0.25	0.72	0.58
Financial Leverage	-0.85	-0.90	-0.84	-0.81	-0.67	-0.75	-0.65	-0.46	0.08	-0.38	0.09
Leverage Ratio	1.23	1.33	1.37	1.43	1.85	1.95	2.14	2.67	3.03	4.06	3.21
Compound Leverage Factor	1.20	1.32	1.42	1.50	1.96	2.11	2.31	2.98	3.45	3.46	2.79
Debt to Total Capital	2.64%	18.83%	22.27%	29.72%	45.92%	70.11%	74.27%	80.13%	63.52%	41.77%	36.82%
Short-Term Debt to Total Capital	2.64%	0.00%	0.00%	0.00%	0.00%	70.11%	74.27%	80.13%	54.32%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	18.83%	22.27%	29.72%	45.92%	0.00%	0.00%	0.00%	9.19%	41.77%	36.82%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	97.36%	81.17%	77.73%	70.28%	54.08%	29.89%	25.73%	19.87%	36.48%	58.24%	63.70%
Debt to EBITDA	-0.02	-0.32	-0.33	-0.32	-0.32	-0.34	-0.33	-0.36	-0.52	-0.29	-0.51
Net Debt to EBITDA	0.69	1.29	0.98	0.59	0.16	-0.12	-0.11	-0.17	-0.22	0.35	0.14
Long-Term Debt to EBITDA	0.00	-0.32	-0.33	-0.32	-0.32	0.00	0.00	0.00	-0.08	-0.29	-0.51
Debt to NOPAT	-0.03	-0.42	-0.43	-0.41	-0.41	-0.43	-0.42	-0.45	-0.64	-0.34	-0.37
Net Debt to NOPAT	0.92	1.72	1.28	0.76	0.21	-0.16	-0.14	-0.21	-0.27	0.41	0.10
Long-Term Debt to NOPAT	0.00	-0.42	-0.43	-0.41	-0.41	0.00	0.00	0.00	-0.09	-0.34	-0.37
Altman Z-Score	-3.87	-3.74	-3.65	-6.26	-9.78	-13.99	-13.52	-13.66	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.65%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.68	7.59	8.43	6.47	3.94	0.93	0.93	0.89	1.16	4.53	3.91
Quick Ratio	4.02	7.14	7.62	5.53	2.79	0.46	0.41	0.32	0.49	2.72	1.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-2.61	-1.59	-2.47	-3.45	-4.98	-6.67	-5.52	-4.58	-7.05	0.21	-6.44
Operating Cash Flow to CapEx	-10,511.03%	-6,761.80%	-7,076.11%	-2,371.80%	-1,342.04%	-4,751.83%	-4,932.68%	-4,619.32%	-2,772.24%	-2,992.88%	-5,235.80%
Free Cash Flow to Firm to Interest Expense	-324.86	0.00	-6.84	-8.88	-12.04	-15.14	-12.01	-9.33	-13.25	0.52	-36.44
Operating Cash Flow to Interest Expense	-355.50	0.00	-12.63	-11.14	-13.25	-11.52	-10.37	-8.86	-10.13	-10.26	-23.46
Operating Cash Flow Less CapEx to Interest Expense	-358.88	0.00	-12.81	-11.61	-14.23	-11.76	-10.58	-9.05	-10.49	-10.60	-23.91
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.06	0.05	0.05	0.05	0.08	0.08	0.09	0.11	0.13	0.14	0.16
Accounts Receivable Turnover	7.63	12.16	8.58	7.65	5.23	5.55	9.60	10.87	4.34	4.15	11.71
Inventory Turnover	0.82	0.69	0.49	0.34	0.34	0.29	0.24	0.20	0.20	0.20	0.18
Fixed Asset Turnover	0.81	0.83	0.81	0.75	0.99	1.20	1.22	1.32	1.31	1.31	1.02
Accounts Payable Turnover	0.61	0.46	0.45	0.44	0.44	0.43	0.33	0.31	0.46	0.54	0.47
Days Sales Outstanding (DSO)	47.86	30.03	42.53	47.69	69.76	65.79	38.03	33.57	84.14	87.93	31.16
Days Inventory Outstanding (DIO)	445.75	530.04	739.09	1,061.56	1,076.19	1,243.71	1,537.75	1,814.33	1,850.12	1,838.09	1,990.79
Days Payable Outstanding (DPO)	599.01	791.61	814.64	838.47	836.16	856.35	1,090.45	1,167.87	789.67	679.70	784.81
Cash Conversion Cycle (CCC)	-105.39	-231.54	-33.01	270.78	309.79	453.15	485.33	680.03	1,144.59	1,246.32	1,237.14
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2.03	0.89	2.24	2.48	3.43	4.26	3.94	4.37	7.92	0.81	6.15
Invested Capital Turnover	0.51	0.65	0.47	0.41	0.46	0.63	0.55	0.55	0.36	0.90	0.47
Increase / (Decrease) in Invested Capital	-0.25	-1.53	0.05	0.31	1.39	3.36	1.70	1.89	4.49	-3.45	2.21
Enterprise Value (EV)	37	3.65	21	17	22	27	36	29	0.00	0.00	0.00
Market Capitalization	45	21	34	25	25	25	34	26	0.00	0.00	0.00
Book Value per Share	$0.69	$0.85	$0.71	$0.51	$0.27	$0.10	$0.07	$0.05	$0.11	$0.15	$0.11
Tangible Book Value per Share	$0.69	$0.85	$0.70	$0.50	$0.27	$0.10	$0.07	$0.05	$0.11	$0.15	$0.11
Total Capital	11	23	20	16	11	7.71	7.76	7.59	12	10	12
Total Debt	0.28	4.26	4.47	4.76	5.07	5.41	5.76	6.08	7.93	4.21	4.25
Total Long-Term Debt	0.00	4.26	4.47	4.76	5.07	0.00	0.00	0.00	1.15	4.21	4.25
Net Debt	-8.41	-17	-13	-8.77	-2.54	1.95	1.94	2.86	3.36	-5.06	-1.14
Capital Expenditures (CapEx)	0.03	0.04	0.06	0.18	0.41	0.11	0.10	0.09	0.19	0.14	0.08
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.37	-1.59	-0.31	-0.06	0.82	1.39	1.23	1.65	3.92	3.55	3.80
Debt-free Net Working Capital (DFNWC)	8.32	20	18	13	8.43	4.85	5.05	4.87	8.49	13	9.19
Net Working Capital (NWC)	8.04	20	18	13	8.43	-0.56	-0.71	-1.21	1.71	13	9.19
Net Nonoperating Expense (NNE)	1.14	1.30	1.18	1.55	1.83	1.82	2.07	1.89	1.64	0.71	-5.07
Net Nonoperating Obligations (NNO)	-8.41	-17	-13	-8.77	-2.54	1.95	1.94	2.86	3.36	-5.06	-1.14
Total Depreciation and Amortization (D&A)	0.25	0.35	0.48	0.50	0.53	0.56	0.57	0.60	0.64	0.42	0.38
Debt-free, Cash-free Net Working Capital to Revenue	-33.94%	-148.53%	-29.56%	-6.13%	64.97%	85.57%	72.61%	87.45%	190.15%	154.96%	159.97%
Debt-free Net Working Capital to Revenue	761.27%	1,877.28%	1,670.51%	1,417.50%	668.73%	297.45%	297.43%	257.98%	411.79%	559.02%	386.56%
Net Working Capital to Revenue	735.35%	1,877.28%	1,670.51%	1,417.50%	668.73%	-34.40%	-41.72%	-64.26%	82.72%	559.02%	386.56%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.26)	($0.20)	($0.17)	($0.21)	($0.24)	($0.23)	($0.23)	($0.16)	($0.10)	$0.02	$0.00
Adjusted Weighted Average Basic Shares Outstanding	15.09M	15.38M	21.78M	22.22M	22.23M	22.27M	25.15M	28.88M	41.02M	39.55M	66.65M
Adjusted Diluted Earnings per Share	($0.26)	($0.20)	($0.17)	($0.21)	($0.24)	($0.23)	($0.23)	($0.16)	($0.10)	$0.02	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	15.09M	15.38M	21.78M	22.22M	22.23M	22.27M	25.15M	28.88M	41.02M	39.55M	78.10M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	21.65M	22.10M	22.22M	22.23M	22.90M	27.15M	0.00	0.00	0.00	0.00	60.39M
Normalized Net Operating Profit after Tax (NOPAT)	-2.86	-3.11	-2.42	-3.14	-3.58	-3.31	-3.82	-2.70	-2.56	-3.24	-2.96
Normalized NOPAT Margin	-1,169.12%	-1,461.52%	-893.95%	-1,416.58%	-645.68%	-568.42%	-1,120.08%	-658.76%	-350.65%	-397.83%	-695.82%
Pre Tax Income Margin	-1,635.66%	-2,067.52%	-1,327.55%	-2,115.87%	-974.52%	-879.25%	-1,729.17%	-1,120.52%	-575.11%	-484.99%	199.13%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-508.06	0.00	-9.58	-11.54	-12.38	-10.72	-11.89	-8.37	-6.92	-11.33	5.51
NOPAT to Interest Expense	-355.64	0.00	-6.70	-8.08	-8.67	-7.51	-8.32	-5.49	-4.81	-7.93	-23.91
EBIT Less CapEx to Interest Expense	-511.44	0.00	-9.76	-12.01	-13.37	-10.97	-12.10	-8.56	-7.28	-11.67	5.06
NOPAT Less CapEx to Interest Expense	-359.03	0.00	-6.88	-8.55	-9.66	-7.75	-8.53	-5.68	-5.17	-8.27	-24.36
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-1.61%	-1.70%	-1.38%	-1.27%	0.00%	0.00%	-4.12%	-9.07%	-9.31%	0.00%

Financials Breakdown Chart

Femasys Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Femasys' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Femasys' net income appears to be on an upward trend, with a most recent value of -$18.63 million in 2025, rising from -$6.91 million in 2020. The previous period was -$18.82 million in 2024. See Femasys' forecast for analyst expectations on what's next for the company.

Femasys' total operating income in 2025 was -$17.59 million, based on the following breakdown:

Total Gross Profit: $1.42 million
Total Operating Expenses: $19.01 million

Over the last 5 years, Femasys' total revenue changed from $1.04 million in 2020 to $2.29 million in 2025, a change of 121.0%.

Femasys' total liabilities were at $14.85 million at the end of 2025, a 46.5% increase from 2024, and a 264.2% increase since 2020.

In the past 5 years, Femasys' cash and equivalents has ranged from $3.32 million in 2020 to $24.78 million in 2021, and is currently $9.27 million as of their latest financial filing in 2025.

Over the last 5 years, Femasys' book value per share changed from -54.00 in 2020 to 0.15 in 2025, a change of -100.3%.

Related Companies

Financial statements for NASDAQ:FEMY last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Femasys (FEMY) Financials

Financials Breakdown Chart

Femasys Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Femasys (FEMY) Financials

Annual Income Statements for Femasys

Quarterly Income Statements for Femasys

Annual Cash Flow Statements for Femasys

Quarterly Cash Flow Statements for Femasys

Annual Balance Sheets for Femasys

Quarterly Balance Sheets for Femasys

Annual Metrics And Ratios for Femasys

Quarterly Metrics And Ratios for Femasys

Financials Breakdown Chart

Femasys Financials - Frequently Asked Questions

When does Femasys' fiscal year end?

How has Femasys' net income changed over the last 5 years?

What is Femasys' operating income?

How has Femasys' revenue changed over the last 5 years?

How much debt does Femasys have?

How much cash does Femasys have?

How has Femasys' book value per share changed over the last 5 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools